Tolerance Clinical Trial
Official title:
Acceptability (Including Gastrointestinal Tolerance and Compliance) of a High Energy, Adult Enteral Formula With Food-derived Ingredients.
Verified date | April 2024 |
Source | Société des Produits Nestlé (SPN) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Enterally fed adults and children who are assessed by the dietitian as requiring an adult high-energy, fibre-containing enteral formula will be recruited. Data from 15 participants are required in order to submit an application to the Advisory Committee on Borderline Substances (ACBS) for product registration.
Status | Completed |
Enrollment | 16 |
Est. completion date | December 22, 2023 |
Est. primary completion date | August 21, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 15 Years and older |
Eligibility | Inclusion Criteria: - Patients requiring an enteral tube feed (taking > 60% of energy needs from their feeding tube) as part of their dietary management for disease related malnutrition - Children 15 years and over - Adults and children requiring an adult high-energy and fibre-containing formula, as assessed by the dietitian. - Patients well-established and stable on enteral feeding. - Willingly given, written, informed consent from patient or consultee - Willingly given, written assent (if appropriate). Exclusion Criteria: - Inability to comply with the study protocol, in the opinion of the investigator - Children under 15 years of age - Patients receiving mechanical ventilation, sedation or inotropic support - Patients on total parenteral nutrition - Known food allergies to any ingredients (see ingredients list) or galactosaemia - Patients with significant renal or hepatic impairment - Patients with planned changes to medication or treatments during the study period which may alter gastrointestinal function (e.g. chemotherapy). Changes in medications or nutritional products during the study intervention must be documented. - Participation in another interventional study within 2 weeks of this study. - Patients with a clinical indication for a low fibre or fibre free diet as advised by the healthcare team. - Patients with known or suspected ileus or mechanical bowel obstruction |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Martha Van Der Linde | Worcester |
Lead Sponsor | Collaborator |
---|---|
Société des Produits Nestlé (SPN) |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Daily patient diaries | Daily monitor of gastrointestinal tolerance using questionnaire on increase, decrease or no change | 14 days | |
Primary | Daily formula intake | mL per day | 14 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05592951 -
Safety and Tolerability of a Novel Amino-acid Based Hydration Drink in Healthy Volunteers
|
N/A | |
Completed |
NCT04689035 -
A Phase 1 Study in Healthy Volunteers to Evaluate the Safety, Tolerability and Pharmacokinetics of AVLX-144
|
Phase 1 | |
Recruiting |
NCT02129296 -
Intragastric Balloon, Air Versus Fluid Filled: Randomized Prospective Study
|
Phase 1/Phase 2 | |
Completed |
NCT06114524 -
Effect of Binaural Beats on Level of Anxiety and Toleration in Patients Undergoing Upper Gastrointestinal Endoscopy Without Sedation
|
N/A | |
Active, not recruiting |
NCT06286488 -
Effectiveness and Tolerability of Influenza Vaccine in Patients at Risk for Severe and Complicated Influenza
|
Phase 4 | |
Completed |
NCT04529759 -
Healthy Term Infants Fed Milk-Based Infant Formula
|
N/A | |
Not yet recruiting |
NCT05428748 -
Clinical Trial to Evaluate Safety and Tolerability of a Novel Hydration Drink in Healthy Volunteers
|
N/A | |
Completed |
NCT04499482 -
Safety and Tolerability of Soy Fiber
|
N/A | |
Recruiting |
NCT01207206 -
Oral Ketamine as an Adjuvant to Opioids for Pain Treatment in Cancer Patients
|
N/A | |
Completed |
NCT01038882 -
Randomized Study With Midazolam for Sedation in Flexible Bronchoscopy
|
N/A | |
Completed |
NCT05794100 -
Evaluating the Impact of Different Sugar Replacer Combinations on Gastrointestinal Tolerance
|
N/A | |
Completed |
NCT06187233 -
The Effects of Binaural Beats on Pain, Anxiety, and Procedure Tolerance in Patients Undergoing Colonoscopy Without Sedation
|
N/A | |
Completed |
NCT04055363 -
Human Milk Oligosaccharides (HMOs) Post-market Study on Infants
|
N/A | |
Recruiting |
NCT03707262 -
Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor
|
Phase 1/Phase 2 | |
Completed |
NCT05585762 -
Buck Institute Ketone Ester RCT
|
N/A | |
Completed |
NCT02307773 -
Lidocaine Spray on an Endoscope to Improve Tolerance to Endoscopy
|
N/A | |
Completed |
NCT04188782 -
Tolerance to Sevoflurane in Children Undergoing Repeated Drug Exposure
|
||
Recruiting |
NCT05527652 -
Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia
|
N/A | |
Recruiting |
NCT05088694 -
The Optimization and Evaluation of the Extremism and Intolerance Curriculum for the Kingdom of Bahrain.
|
N/A | |
Completed |
NCT02144402 -
Growth of Healthy Term Infants Fed Formula Containing DHA-B
|
N/A |